10-37130304-G-A
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_052997.3(ANKRD30A):c.436G>A(p.Ala146Thr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ANKRD30A
NM_052997.3 missense
NM_052997.3 missense
Scores
5
9
4
Clinical Significance
Conservation
PhyloP100: 4.02
Publications
0 publications found
Genes affected
ANKRD30A (HGNC:17234): (ankyrin repeat domain 30A) This gene encodes a DNA-binding transcription factor that is uniquely expressed in mammary epithelium and the testis. Altered expression levels have been associated with breast cancer progression. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.845
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_052997.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANKRD30A | TSL:5 MANE Select | c.436G>A | p.Ala146Thr | missense | Exon 3 of 36 | ENSP00000354432.2 | Q9BXX3 | ||
| ANKRD30A | TSL:5 | c.436G>A | p.Ala146Thr | missense | Exon 3 of 42 | ENSP00000363792.2 | Q5W026 | ||
| ANKRD30A | TSL:5 | c.436G>A | p.Ala146Thr | missense | Exon 3 of 36 | ENSP00000473551.2 | Q9BXX3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000207 AC: 3AN: 1450940Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 721836 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3
AN:
1450940
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
721836
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32536
American (AMR)
AF:
AC:
0
AN:
42772
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25944
East Asian (EAS)
AF:
AC:
1
AN:
38668
South Asian (SAS)
AF:
AC:
0
AN:
85066
European-Finnish (FIN)
AF:
AC:
0
AN:
53284
Middle Eastern (MID)
AF:
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
AC:
2
AN:
1107112
Other (OTH)
AF:
AC:
0
AN:
59828
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at H144 (P = 0.2062)
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.